V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007499 | 190001927 | 1.77 | 71.8 | Curative (C) | 2018-08-10 | 2018-08-10 | Cisplatin | 02 | null | CISPLATIN | 101176230 |
| 190007503 | 190001928 | 1.5 | 110 | Curative (C) | 2017-10-05 | 2017-10-06 | Cisplatin 7 day | 02 | N | CISPLATIN | 101464057 |
| 190007506 | 190001930 | null | null | null | null | 2018-03-31 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101372805 |
| 190007509 | 190001931 | 1.79 | 72 | Curative (C) | 2019-04-14 | 2019-04-22 | Cisplatin | N | N | CISPLATIN | 100333839 |
| 190007518 | 190001934 | null | null | null | null | 2018-08-27 | ECX | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100460744 |
| 190007520 | 190001935 | 1.8 | 47 | Curative (C) | 2016-06-29 | 2016-07-08 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100427636 |
| 190007521 | 190001936 | 1.58 | 83.2 | Curative (C) | 2016-10-20 | 2016-10-21 | Oxaliplatin + Modified de Gramont | 02 | N | CISPLATIN + RT | 101655712 |
| 190007529 | 190001938 | null | null | null | null | 2016-07-25 | Cisplatin+Gemcitabine (gallbladder) | null | null | CISPLATIN + GEMCITABINE | 101009410 |
| 190007533 | 190001940 | 1.59 | 65.3 | Adjuvant (A) | 2018-12-29 | 2018-12-30 | Carboplatin AUC 2 - 5 | 02 | Y | DASATINIB | 101565691 |
| 190007542 | 190001941 | null | null | null | null | 2017-08-08 | Carboplatin + Liposomal Doxorubicin | null | null | LANREOTIDE | 100650272 |
| 190007546 | 190001943 | null | null | null | null | 2019-03-18 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101183946 |
| 190007551 | 190001945 | null | null | null | null | 2022-05-19 | Dox + HD Mtx (post PAM) | null | null | CISPLATIN + RT | 100791068 |
| 190007552 | 190001946 | null | null | null | null | 2018-06-07 | VIDE | null | null | CARBOPLATIN + GEMCITABINE | 100587695 |
| 190007561 | 190001948 | null | null | null | null | 2016-07-05 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100883797 |
| 190007571 | 190001952 | 1.6 | 77.8 | Adjuvant (A) | 2016-11-16 | 2016-11-16 | Pazopanib | 01 | N | CAPECITABINE + CARBOPLATIN | 101763490 |
| 190007587 | 190001959 | null | null | null | null | 2018-03-10 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100115216 |
| 190007589 | 190001960 | null | null | null | null | 2018-01-10 | Bortezomib + CYCLOPHOSPHAMIDE + Dexamethasone | null | null | FLUOROURACIL + OXALIPLATIN | 101819953 |
| 190007598 | 190001962 | 1.77 | 92.7 | Adjuvant (A) | 2017-08-14 | 2017-08-22 | Capecitabine + Oxaliplatin 21day | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101687459 |
| 190007603 | 190001964 | 0 | 50.6 | Palliative (P) | 2019-10-28 | 2019-11-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101675690 |
| 190007604 | 190001965 | 1.79 | 79.5 | Neo-adjuvant (N) | 2016-11-23 | 2016-11-30 | Carboplatin + Paclitaxel (3 weekly) | Y | N | CAPECITABINE + CARBOPLATIN | 100178264 |
| 190007605 | 190001966 | null | null | null | null | 2017-05-23 | Cisplatin 7 day | null | null | CISPLATIN | 100500355 |
| 190007611 | 190001968 | null | null | null | null | 2021-01-06 | Capecitabine + Oxaliplatin 21day | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101136583 |
| 190007616 | 190001969 | 1.78 | 57 | Palliative (P) | null | 2018-06-08 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100803791 |
| 190007623 | 190001971 | null | 49.2 | Palliative (P) | 2017-10-02 | 2017-10-03 | VIDE | 02 | N | FLUOROURACIL + OXALIPLATIN | 100179928 |
| 190007632 | 190001974 | 1.51 | 85 | null | 2016-04-14 | 2016-04-14 | Dasatinib | 01 | null | CISPLATIN + ETOPOSIDE | 100557877 |
| 190007633 | 190001975 | null | null | null | null | 2017-12-15 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100155829 |
| 190007634 | 190001976 | null | null | null | null | 2016-02-18 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100639159 |
| 190007635 | 190001977 | 1.72 | 68 | Palliative (P) | 2016-02-04 | 2016-02-04 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100693012 |
| 190007643 | 190001983 | 1.66 | 73 | Palliative (P) | 2017-10-09 | 2017-10-16 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100104703 |
| 190007645 | 190001985 | null | null | null | null | 2016-08-07 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100261474 |
| 190007649 | 190001986 | 1.72 | 68.4 | null | 2017-03-23 | 2017-03-23 | CARBOPLATIN + ETOPOSIDE | N | N | CARBOPLATIN + ETOPOSIDE | 100001004 |
| 190007654 | 190001988 | null | null | null | null | 2017-01-10 | Cisplatin + Radiotherapy | null | null | EW EUROEWING 2012 ARM A VIDE | 100572959 |
| 190007659 | 190001990 | 1.67 | 73 | Neo-adjuvant (N) | 2016-11-05 | 2016-11-05 | Capecitabine | 02 | N | CAPECITABINE + MITOMYCIN | 101676691 |
| 190007666 | 190001993 | 1.6 | 46.5 | Curative (C) | 2017-01-12 | 2017-02-09 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100795617 |
| 190007674 | 190001997 | 1.6 | 79.15 | Palliative (P) | 2016-02-06 | 2016-03-04 | OST Euramos 1 Closed Trial - AP | 02 | N | GEMCARBO | 101596597 |
| 190007678 | 190001999 | null | null | null | null | 2016-06-23 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 101435177 |
| 190007680 | 190002000 | 1.68 | 30.3 | Curative (C) | 2016-09-22 | 2016-09-23 | EW EuroEwing 2012 Arm A VAI | N | N | CISPLATIN + RT | 100528330 |
| 190007686 | 190002002 | 1.66 | 86.8 | Curative (C) | 2018-10-01 | 2018-10-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | BLEOMYCIN + CISPLATIN + VINCRISTINE | 101026186 |
| 190007697 | 190002007 | null | null | null | null | 2019-02-26 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100118538 |
| 190007700 | 190002009 | 1.55 | 57.5 | 03 | 2017-10-09 | 2017-10-09 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100339505 |
| 190007701 | 190002010 | 1.66 | 66 | Curative (C) | 2016-09-21 | 2016-10-13 | CISPLATIN + GEMCITABINE | 02 | Y | CISPLATIN + GEMCITABINE | 100415934 |
| 190007716 | 190002013 | 1.95 | 79.2 | 03 | 2019-12-14 | 2019-12-15 | Cisplatin + Radiotherapy + CISPLATIN | null | Y | CISPLATIN | 101506535 |
| 190007733 | 190002018 | null | null | null | null | 2018-02-12 | Cisplatin 7 day | null | null | CISPLATIN | 100681728 |
| 190007749 | 190002022 | 1.82 | 71 | Curative (C) | 2018-06-24 | 2018-06-25 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | CISPLATIN + GEMCITABINE | 100048445 |
| 190007755 | 190002025 | null | null | null | null | 2018-11-28 | NB HRNBL-1 COJEC Ind COURSE A | null | null | LANREOTIDE | 101408885 |
| 190007757 | 190002026 | 1.84 | 101.2 | Palliative (P) | 2020-02-13 | 2020-02-13 | CARBOPLATIN + RT | N | N | CETUXIMAB | 100897403 |
| 190007767 | 190002029 | null | null | null | null | 2018-12-03 | CISPLATIN + RT | null | null | CISPLATIN | 101164075 |
| 190007771 | 190002031 | null | null | null | null | 2018-10-14 | CNS ATRT Doxorubicin + GCSF | null | null | CAPECITABINE + CARBOPLATIN | 100944246 |
| 190007772 | 190002032 | 1.61 | 121 | Neo-adjuvant (N) | 2017-02-09 | 2017-02-09 | CISPLATIN + GEMCITABINE | N | N | CISPLATIN + GEMCITABINE | 100349229 |
| 190007776 | 190002035 | null | null | null | null | 2014-08-07 | Cisplatin + Radiotherapy | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101049319 |